Soluble Fas levels in patients with systemic sclerosis

被引：5

作者：

Bianchi, T ^{[1
]}

Bardazzi, F ^{[1
]}

Patrizi, A ^{[1
]}

机构：

[1] Univ Bologna, Div Dermatol, Dept Clin & Expt Med, Bologna, Italy

来源：

ARCHIVES OF DERMATOLOGICAL RESEARCH | 2000年 / 292卷 / 10期

关键词：

serum soluble Fas; systemic sclerosis; apoptosis;

D O I：

10.1007/s004030000170

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：522 / 523

页数：2

共 5 条

[1]

Bunn CC, 1999, CLIN EXP IMMUNOL, V117, P207

[2] Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity [J].

De Maria, R ;

Testi, R .

IMMUNOLOGY TODAY, 1998, 19 (03) :121-125

[3] Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases [J].

Nozawa, K ;

Kayagaki, N ;

Tokano, Y ;

Yagita, H ;

Okumura, K ;

Hasimoto, H .

ARTHRITIS AND RHEUMATISM, 1997, 40 (06) :1126-1129

[4] Soluble Fas molecule in the serum of patients with systemic lupus erythematosus [J].

Tokano, Y ;

Miyake, S ;

Kayagaki, N ;

Nozawa, K ;

Morimoto, S ;

Azuma, M ;

Yagita, H ;

Takasaki, Y ;

Okumura, K ;

Hashimoto, H .

JOURNAL OF CLINICAL IMMUNOLOGY, 1996, 16 (05) :261-265

[5] Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis [J].

Wetzig, T ;

Petri, JB ;

Mittag, M ;

Haustein, UF .

ARCHIVES OF DERMATOLOGICAL RESEARCH, 1998, 290 (04) :187-190

← 1 →